The global non-surgical rhinoplasty market size is expected to reach USD 1.3 billion by 2030, registering a CAGR of 8.1% according to a new report by Grand View Research, Inc. Non-surgical rhinoplasty, also known as liquid rhinoplasty is a non-invasive cosmetic procedure used to alter the shape and define a person’s nose by using injectable fillers such as hyaluronic acid fillers. This method offers immediate results, no downtime, is less invasive, and is inexpensive. All these factors are expected to fuel the growth of the market.
Non-surgical rhinoplasty can be done in case a person has a dorsal bump, asymmetrical shape of the nose, dip in the nose bridge, improve/camouflage deformities, or treat mildly crooked nose. However, this procedure is only carried out to smooth out nasal imperfections and fix minor symmetry issues and cannot treat major nasal defects.
Injectable fillers like HA fillers and CaHa fillers are most commonly used in liquid Rhinoplasty procedures. However, as per Medical News Today, HA injectables are widely preferred and adopted by plastic surgeons and this is because these fillers are biocompatible, have a natural feel, provide a defined shape and complications can be reversed using hyaluronidase injection.
The market witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. However, it is expected to witness a recovery as the demand for non-invasive aesthetic treatments saw significant growth post-pandemic. This is majorly due to increased virtual meets, increased disposable income, high social media impact, and desirability to improve aesthetic appearance. According to the American Society of Plastic Surgeons (ASPS), the pandemic led to an increase in the acceptance of cosmetic procedures
Request a free sample copy or view report summary: Non-surgical Rhinoplasty Market Report
The HA filler segment is projected to dominate the market throughout the forecast period. It is the most preferred and highly adopted filler due to its biocompatibility and aesthetic benefits
The minor nasal asymmetry application wheelchairs segment is projected to witness rapid growth over the forecast period as slight nasal misalignment due to genetics or minor injuries is expected to be prevalent in the global population
The MedSpa end-use segment dominated the market owing to comprehensive services offered by such facilities, high accessibility, adoption of advanced products and technology as well as the availability of cost-effective treatments
North America accounted for the highest revenue share in 2022 due to high awareness about non-invasive aesthetic treatment and the presence of major key players
Asia Pacific is expected to grow at a CAGR of 8.8% over the forecast period, owing to the rising awareness and adoption of cosmetic treatments in Asian countries
Grand View Research has segmented the global non-surgical rhinoplasty market based on filler type, application, end-use and region:
Non-surgical Rhinoplasty Filler Type Outlook (Revenue, USD Million; 2018 - 2030)
Hyaluronic Acid Fillers
CaHa Fillers
Non-surgical Rhinoplasty Application Outlook (Revenue, USD Million; 2018 - 2030)
Indentations of dorsal hump
Convex Nose
Minor Nasal Asymmetry
Others
Non-surgical Rhinoplasty End Use Outlook (Revenue, USD Million; 2018 - 2030)
MedSpa
Hospital/Surgery Center
HCP-owneded clinic
Non-surgical Rhinoplasty Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
List Of Key Players Of Non-surgical Rhinoplasty Market
SKINovative of Gilbert - Medical Spa
The London Cosmetic Clinic
Laser Clinic United Kingdom
Therapie Clinic
Toronto Cosmetic Clinic (TCC)
Canada MedLaser, Inc.
Skin Vitality Medical Clinic
True MediSpa
Nova Aesthetic Clinic
VIVA Skin Clinic
Piedmont Plastic Surgery & Dermatology
"The quality of research they have done for us has been excellent..."